A PBPK model for benzo(A)pyrene in the rat
D. Moir +4 more
openaire +1 more source
Understanding Postmarketing Requirements and Commitments for CYP3A-Mediated Drug-Drug Interactions: An Analysis of FDA-Approved Drugs From 2015 to 2024. [PDF]
Yu J +4 more
europepmc +1 more source
Physiologically Based Pharmacokinetic (PBPK) Modeling of Antidepressants: A Scoping Review of Existing Models, Applications, and Software Tools. [PDF]
Huber RL, Scherf-Clavel O.
europepmc +1 more source
The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology. [PDF]
van der Gaag S +4 more
europepmc +1 more source
Physiologically Based Pharmacokinetic Modeling for Mechanistic Analysis of Food Effects: A Case Study with Radotinib. [PDF]
Kang M +5 more
europepmc +1 more source
Development of a Disease-Specific Virtual Malaria Population for Physiologically-Based Pharmacokinetic Modeling. [PDF]
Ding J, Pei Q, Hoglund RM, Tarning J.
europepmc +1 more source
Physiologically Based Pharmacokinetic (PBPK) Modeling of FIX in Pediatric Hemophilia B: Extravascular Distribution and Dosing Optimization. [PDF]
Liu M +7 more
europepmc +1 more source
Narrow Therapeutic Index Drugs: Regulatory Frameworks, Bioequivalence, and Model-Informed Precision Dosing. [PDF]
Liu M +7 more
europepmc +1 more source
PBPK Modeling of Esomeprazole to Support Adolescent Pharmacokinetic Extrapolation and Label Extension in Chinese Patients With Gastroesophageal Reflux Disease (GERD). [PDF]
Jin Y +11 more
europepmc +1 more source
Artificial Intelligence in the Design and Development of Nanoparticle Drug Delivery Systems: A Systematic Review. [PDF]
Haddad R.
europepmc +1 more source

